DavidWerdegarMD

PubMed

• 2 citations
  Clients entering drug abuse day treatment: 18-month outcomes.
  Joseph Guydish, David Werdegar, Barbara Tajima, Marilyn Price, Alfonso Acampora> ;The American Journal of Drug and Alcohol Abuse. 1997 Feb 1
• 7 citations
  A day treatment program in a therapeutic community setting : six-month outcomes : the Walden House day treatment program
  Joseph Guydish, David Werdegar, James L. Sorensen, Wayne M. Clark, Alfonso Acampora> ;Journal of Substance Abuse Treatment. 1995 Nov 1
• 53 citations
  The epidemiology of AIDS-related Kaposi's sarcoma in San Francisco.
  George W. Rutherford, Sandra Schwarcz, George F. Lemp, J. Lowell Barnhart, Kathryn J. Rauch, W. L. Warner, Timothy H. Piland, David Werdegar> ;The Journal of Infectious Diseases. 1989 Mar 1
• 7 citations
  The epidemiology of acquired immunodeficiency syndrome.
  George W. Rutherford, David Werdegar> ;Immunology Series. 1989 Jan 1
• 1 citations
  Guidelines for the control of human immunodeficiency virus infection in adolescents.
  Geraldine E. Oliva, George W. Rutherford, Moses Grossman, Janet Shalwitz, Abigail English, Frances Taylor, David Werdegar> ;The Western Journal of Medicine. 1988 May 1
• 374 citations
  Relationship Between Level of Blood Pressure Measured Casually and by Portable Recorders and Severity of Complications in Essential Hypertension
  Maurice Sokolow, David Werdegar, Herbert K. Kain, Allen T. Hinman> ;Circulation. 1966 Aug 1
• 26 citations
  A technique for continuous measurement of arterial blood pressure in unanesthetized monkeys
  David Werdegar, Dale G. Johnson, John W. Mason> ;Journal of Applied Physiology. 1964 May 1
• 10 citations
  ENTERIC PROTEIN LOSS WITH HYPOPROTEINEMIA IN DIFFUSE LYMPHOSARCOMA OF THE BOWEL.
  David Werdegar, Howard Adler, Charles Watlington> ;Annals of Internal Medicine. 1963 Aug 1
• HIV education and prevention in California: problems and progress. HIV Education and Prevention Evaluation Team.
  Marx, R., Franks, P. E., Kahn, J. G., Sanstad, K. C., Werdegar, D.> ;AIDS Public Policy J. 1997
• A randomized trial comparing day and residential drug abuse treatment: 18-month outcomes.
  Guydish, J., Sorensen, J. L., Chan, M., Werdegar, D., Bostrom, A., Acampora, A.> ;J Consult Clin Psychol. 1999 Jun
• Guidelines for infection control aspects of employee health.
  Werdegar, D.> ;APIC. 1977 Dec
• State of the state's health care.
  Coye, M. J., Powers, P., Kerr, C. E., Noce, W. W., Werdegar, D., Corlin, R. F., Melnick, G.> ;Calif Hosp. 1992 Jan 01
• Drug abuse day treatment: a randomized clinical trial comparing day and residential treatment programs.
  Guydish, J., Werdegar, D., Sorensen, J. L., Clark, W., Acampora, A.> ;J Consult Clin Psychol. 1998 Apr
• Employee health.
  Werdegar, D.> ;Nurs Clin North Am. 1980 Dec
• Portable recordings of blood pressure: a new approach to assessments of the severity and prognosis of hypertension.
  Werdegar, D., Sokolow, M., Perloff, D. B.> ;Trans Assoc Life Insur Med Dir Am. 1968
• Blood pressure responses to daily life events.
  Riess, W. F., Werdegar, D., Sokolow, M.> ;Trans Assoc Life Insur Med Dir Am. 1968
• Preliminary studies relating portably recorded blood pressures to daily life events in patients with essential hypertension.
  Sokolow, M., Werdegar, D., Perloff, D. B., Cowan, R. M., Brenenstuhl, H.> ;Bibl Psychiatr. 1970
• Impressions of health care and medical education in Japan.
  Rodnick, J. E., Werdegar, D.> ;Fam Med. 1985 Jul 01
• Nosocomial respiratory tract infection and colonization with Acinetobacter calcoaceticus. Epidemiologic characteristics.
  Buxton, A. E., Anderson, R. L., Werdegar, D., Atlas, E.> ;Am J Med. 1978 Sep
• Join now to see all